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HIGHLIGHTS 
There were no significant differences in chymase levels between groups NS1 (+) and NS1 (-) 
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Thrombocytopenia, leukopenia, and monocytosis are laboratory 
parameters in the diagnosis of dengue virus infection. In addition to 
monocyte cells, mast cells also play a role in the innate immune 
response, where degranulation of mast cells will occur, which will 
secretion the active vaso mediator, Chymase. Chymase has a role in 
increasing vascular permeability resulting in plasma leakage in 
patients with dengue virus infection to determine the number of 
platelets, leukocytes, monocytes and chymase levels in patients with 
dengue infection in the acute phase. The platelet count mean in NS1 
(+) was 132,140 cells / mm3 and the platelet count in the NS1 group 
was (-) 176,000 cells / mm3. The mean leukocytes NS1 (+) showed 
results of 4,350 cells / mm3 and NS1 (-) 5,250 cells / mm3. The mean 
monocyte NS1 (+) monocyte count was 8.26%, and NS1 (-) group 
was 8.76%. There were no significant differences in platelet counts, 
leukocytes and monocytes between NS1 (+) and NS1 (-) (P value> 
0.05). The mean Chymase NS1 (+) 23.48, NS1 (-) 23.05 ng / mL and 
the control group 1.47ng / mL. 
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1. INTRODUCTION 
World Health Organization (WHO) estimates that 40% of the world's population of around 2.5 
billion people living in tropical and sub-tropical regions are at risk of contracting dengue virus 
infection. In Indonesia, this disease has been occurring every year for 45 years.1 This virus consists 
of four types of serotypes (DENV1, DENV2, DENV3 and DENV4).2 Dengue virus infection in humans 
results in a varied spectrum of clinical manifestations. Most DENV infections are asymptomatic or 
have mild symptoms, with a small proportion experiencing Dengue Hemorrhagic Fever (DHF) and 
Dengue Shock Syndrome (DSS). Clinical manifestations for DHF and DSS include dengue fever, 
thrombocytopenia, vascular permeability and plasma leakage.3 
The innate immune response awakens immediately after the infected Aedes mosquito 
inoculates DENV into the skin. Immune cells that are targeted by DENV are myeloid groups, namely 
phagocytic cells, including dendritic cells and monocyte cells. Monocytes and DC cells will be 
recruited significantly to the skin that has DENV infection. Monocytes and DCs can detect the 
presence of DENV using pathogen recognition receptors (PRRs), including TLRs, RLRs and CLRs. 
Activation of PRRs by DENV will activate intracellular pathway signaling which will induce 
inflammatory cytokines and anti-viral immunity through the production of type I Interferon (IFN) 
namely IFN α and IFN β.4 
Like Langerhans dendritic cells, mast cells also interact with DENV in the early stages of 
infection. However, cell mast interactions with DENV differ from the type of Antigen-Presenting Cell 
(APC), which is the target of infection. Mast cells will experience degranulation within a few minutes 
after being exposed to DENV and will produce cytokines in the next few hours. Degranulation of 
mast cells will produce inflammatory mediators.5 Chymase from mast cells will support increased 
vascular permeability both indirectly with the production of bradykinin, as well as the possibility of 
direct mechanism.6,7 Chymase can cause degradation of junction cells, which can cause increased 
permeability.8 The mechanism of action of the chymase is evident that tight junction protein (for 
example, Claudin 4, Claudin 5 and Occludin) are closely related to chymase both directly and 
indirectly. It is clear that the degradation of several proteins supports inflammation by migrating 
leukocytes through the endothelium.9,10 
 
 
2. MATERIALS AND METHOD 
The sample was collected from patients with dengue virus infection in Dr. Darsono Hospital, 
Pacitan. Inclusion criteria included patients aged 17-60 years, having fever for 2-7 days, NS1 
examination results showing positive (+) and NS1 (-) diagnosing dengue virus infection in medical 
records and willing to sign informed consent. While the exclusion criteria are patients with dengue 
fever infection who meet the inclusion criteria with asthma, urticaria and diarrhea. The sample was 
59 patients during January - March 2019. Patients were taken for blood on the first day of hospital 
admission for NS1 examination and complete blood examination in the laboratory. The serum is 
collected from patients who have diagnosed DF / DHF based on the rules of the World Health 
Organization (WHO) and examined Chymase levels at the Pathology Laboratory of the Gadjah Mada 
University in Yogyakarta. Approval of ethical clearance was obtained from the Faculty of Dentistry 
of Airlangga University Surabaya with Number 004 / HRECC.FODM / I / 2019. NS1 examination was 
carried out with the Panbio early detection brand rapid test. Chymase examination is done using 
Human Chymase 1, Mast Cell ELISA KIT from Bioassay Technology Laboratory. 
 
 
3. RESULTS AND DISCUSSION 
The number of samples obtained was 59 samples consisting of 49 samples with positive NS1 
results (+) and ten samples with negative NS1 (-). The results showed that the NS1 (+) group was 
dominated by a male as much as 67.3% (33 people), while female 32.7%. There was a significant 
relationship between sex and dengue fever, where the results showed that men had a risk of 4.99 
times higher than a woman.11 Moreover, men have relatively higher work activities and mobilization 
than women.12 
 
Table 1. Characteristics of DHF patients 
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Characteristics (n = 59) Non-Structural (NS) 1  P value 
Positive (+) Negative (-) 
NS1 Test 49 10 - 
Gender      0,301** 
       Male 33 (67,3%) 5 (50%)  
       Female  16 (32,7%) 5 (50%)   
Age Group   0,178* 
       Late adolescent (17-25)  19 (38,8%)  1 (10%)   
       Young adult (26-35) 10 (20,4%) 6 (60%)  
       Late adult (36-45)  10 (20,4%)  0   
       Early elderly (46-55)  10 (20,4%)  3 (30%)   
    
 
Grouping characteristics by age, in the NS1 (+) group, was dominated by late adolescents 
(17-25 years), as many as 38.8% (19 people). This is in line with the results of the 2017 study by 
Deborah and Joshi in 2018, showing that there was an increase in the distribution of dengue fever 
in adolescents and adults. Age is one of the internal factors related to a person's behaviour or 
community. Age is related to daily activities inside and outside because Aedes Sp has a biting habit 
in the morning and evening.11 The results of different tests for the sex group and age between NS1 
(+) and NS1 (-) showed that there were no significant differences. This happens because NS1 affects 
the severity of dengue disease but does not depend on the sex and age of the host. 
  Table 2. Blood Test Result of DHF Patients 
Characteristics (n = 59) 
Non-Structural (NS) 1  P value Normal Value Positive (+) Negative (-) 
Platelet Count (cell/mm3)   150.000 -  
   Mean ± SD  132.140±69.285 176.000±53.337  0,064* 450.000 
   Modus 156.000 74.000   
   Max-Min 
 12.000 s/d 
378.000 
 74.000 s/d 
187.000     
Leucocytes Count (cell/mm3)   
    3.800 - 
11.000 
   Mean ± SD  4.350 ± 1,95  5.250 ± 1,28  0,172*   
   Modus 2 2.8   
   Max-Min  1.500 s/d 9.500  2.800 s/d 7.870     
% Basophil    0-1 
   Mean ± SD  0,15 ± 0,17  0,40 ±0,00  0,000**    
   Modus 0,1 0,4   
   Max-Min  0,0 s/d 0,9 0,4      
% Monocyte    2-8 
   Mean ± SD 8,26 ± 3,19  8,76 ±3,28  0,592**   
   Modus 5,10 8,70   
   Max-Min 4,10 s/d 18,30  5,50 s/d 16,90     
% Lymphocyte    25-40 
   Mean ± SD  22,3 ± 11,96 27,7 ± 9,78   0,084**   
   Modus 10,3 14,7   
   Max-Min  7,3 s/d 52,9  14,7 s/d 44,2      
The results of peripheral blood tests will change during dengue infection. However, the results 
showed that there was no significant increase in the leukocyte cell counts in the NS1 (+) group 
showing the results of 4,350 cells/mm3 and NS1 (-) 5,250 cells/mm3. The results of leukocyte count 
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still in normal value, which is consistent with the Jatmiko study, 2018 where this was due to the 
recent course of the disease (the fever of the research subjects averaged four days) and the degree 
of disease that was not severe. Leukopenia in dengue virus infection occurs due to severe bone 
marrow suppression and occurs in infections that last longer and close to the healing phase.13 
 The results of platelet count in the NS1 (+) group experienced a slight decrease of 132,140 
cells/mm3, while in the NS1 (-) group it was still within the normal range of 176,000 cells/mm3. The 
different platelet test between NS1 (+) and NS1 (-) groups shows the results of the value of P> 0.05, 
which means there is no significant difference. This can occur because many things affect the 
occurrence of thrombocytopenia in patients with dengue virus infection, including bone marrow 
suppression, platelet sequestration, megakaryocyte infection, destruction of platelets due to the 
presence of antiplatelet autoantibodies, and platelet apoptosis. The interaction between these 
factors and the use of K3EDTA anticoagulants could be the cause of no significant differences 
between NS1 (+) and NS1 (-).11,14 
The results of a differential count examination, especially the number of lymphocytes and 
basophils did not increase. Monocyte cell counts had a slight increase where on the NS1 (+) group 
monocyte count was 8.26% and NS1 (-) group was 8.76%. This is consistent with the study of Tsai 
et al., 2017, which states that monocytosis (a significant increase in the number of monocytes) 
occurs starting on the fifth day. The number of monocytes will continue to increase on the sixth and 
seventh days after a fever. Monocytes are the main target of the dengue virus, the dengue virus that 
enters the monocytes will increase cross-reactive antibodies by antibodies which increases in 
number. Monocytosis, along with thrombocytopenia, is the initial guide and is consistent in the 
diagnosis of dengue and severe dengue markers.12 Activated platelets are containing the dengue 
virus form aggregations with monocytes during the critical stages of the disease. This shows the 
possible role of cleansing the virus and the causes of thrombocytopenia implemented by innate 
phagocytic immune cells. Sequential sequences of events including low platelet counts and transient 
monocytosis, increasing phagocyte activity during dengue virus infection, can cause the release of 
large numbers of dissolved factors to induce DHF.15 
The results of different tests on complete blood test parameters did not show a significant 
difference. This happens because the infection of the dengue virus is still in the initial phase, so 
excessive destruction has not occurred.11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chymase Levels in the Control Group, DHF Patients with NS1 (+) and NS1 (-) 
 
Chymase levels in patients in the NS1 positive (+) group (n = 49) showed no significant 
difference in the NS1 negative group (n = 10). From the figure 1, it can be explained that the chymase 
level in the NS1 (+) group has an average that is almost the same as the NS1 (-) group. Based on 
statistical tests with the one-way ANOVA test obtained a value of P value> 0.05 which can be 
concluded that there is no significant difference between the chymase levels in the NS1 (+) and NS1 
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(-) groups. The results showed a significant difference between chymase levels in the control group 
with NS1 (+) and between the control group and NS1 (-) group. 
 Mast cells can produce many vasoactive mediators that have a function in inducing vascular 
permeability. Some of them are stored and can act almost instantly on the vascular endothelium, 
TNF, protease (tryptase and chymase) and heparin. Other vasoactive factors include leukotriene, 
prostaglandin, VEGF. With their activation, the factors released by mast cells act together to promote 
the degradation of junction cells, plasma leakage and oedema in tissues. The results of the study 
are not following the research reported by previous researchers that chymase levels will increase 
very significant in DF (tenfold) and DHF (thirty-fold) in the acute phase. This happens because other 
vasoactive factors besides chymase can degrade junction cells and cause plasma leakage in DHF 
patients.  
 
4. CONCLUSION 
There were no significant differences in chymase levels between groups NS1 (+) and NS1 (-). 
Significant differences in chymase levels were found between the control group with NS1 (+) and 
the control group with NS1 (-) in dengue virus infection. The decrease in platelets occurs very slightly 
below normal, with a slight increase in the number of monocyte cells. 
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